Clinical Trial Update: A Study of Belimumab in the Prevention of Kidney Transplant Rejection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating belimumab to prevent kidney transplant rejection has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Transplantation, Organ | Phase 2 | Status: COMPLETED | Results posted: 2017-04-25